Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for LifeMD, Inc. (LFMD : NSDQ)

• Company Description    LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers. LifeMD Inc., formerly known as Conversion Labs, is based in NEW YORK. Number of Employees: 389

• Price / Volume Information    Yesterday's Closing Price: $2.13 Daily Weekly Monthly 20 Day Moving Average: 703,726 shares Shares Outstanding: 48.20 (millions) Market Capitalization: $102.67 (millions) Beta: 1.99 52 Week High: $6.44 52 Week Low: $2.10 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -26.80% -26.03% 12 Week -41.48% -42.91% Year To Date -37.54% -43.16%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 236 FIFTH AVENUE SUITE 400 - NEW YORK,NY 10001 USA ph: 866-351-5907 fax: - ir@lifemd.com http://www.lifemd.com

• General Corporate Information    Officers Justin Schreiber - Chief Executive Officer and Chairman Marc Benathen - Chief Financial Officer Roberto Simon - Director John Strawn - Director Joseph DiTrolio - Director Peer Information LifeMD, Inc. (CHCR) LifeMD, Inc. (ESRX) LifeMD, Inc. (MYDP) LifeMD, Inc. (COR) LifeMD, Inc. (GBCS) LifeMD, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 53216B104 SIC: 8011 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/09/26 Share - Related Items Shares Outstanding: 48.20 Most Recent Split Date: 10.00 (0.20:1) Beta: 1.99 Market Capitalization: $102.67 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.03 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.48 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/09/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 12.93 Price/Cash Flow: - Price / Sales: 0.50 EPS Growth vs. Year Ago Period: -166.67% vs. Previous Quarter: 20.00% Sales Growth vs. Year Ago Period: -24.01% vs. Previous Quarter: -5.75% ROE 09/30/26 - - 06/30/26 - -168.23 03/31/26 - -150.88 ROA 09/30/26 - - 06/30/26 - -31.27 03/31/26 - -22.59 Current Ratio 09/30/26 - - 06/30/26 - 0.90 03/31/26 - 1.04 Quick Ratio 09/30/26 - - 06/30/26 - 0.84 03/31/26 - 0.98 Operating Margin 09/30/26 - - 06/30/26 - -10.19 03/31/26 - -7.21 Net Margin 09/30/26 - - 06/30/26 - 0.10 03/31/26 - 2.37 Pre-Tax Margin 09/30/26 - - 06/30/26 - -10.51 03/31/26 - -7.94 Book Value 09/30/26 - - 06/30/26 - 0.16 03/31/26 - 0.32 Inventory Turnover 09/30/26 - - 06/30/26 - 7.76 03/31/26 - 8.07 Debt-to-Equity 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00 Debt-to-Capital 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00

Powered by Zacks Investment Research ©